vs
Side-by-side financial comparison of BayCom Corp (BCML) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $13.8M, roughly 1.9× Gossamer Bio, Inc.). BayCom Corp runs the higher net margin — 26.5% vs -342.3%, a 368.8% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 9.4%).
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
BCML vs GOSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.9M | $13.8M |
| Net Profit | $6.9M | $-47.2M |
| Gross Margin | — | — |
| Operating Margin | 36.6% | -333.6% |
| Net Margin | 26.5% | -342.3% |
| Revenue YoY | 9.4% | 47.1% |
| Net Profit YoY | 12.1% | -43.0% |
| EPS (diluted) | $0.63 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.9M | $13.8M | ||
| Q3 25 | $25.7M | $13.3M | ||
| Q2 25 | $24.7M | — | ||
| Q1 25 | $24.3M | — | ||
| Q4 24 | $23.7M | — | ||
| Q3 24 | $25.6M | — | ||
| Q2 24 | $23.8M | $95.8M | ||
| Q1 24 | $24.5M | $0 |
| Q4 25 | $6.9M | $-47.2M | ||
| Q3 25 | $5.0M | $-48.2M | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $5.7M | — | ||
| Q4 24 | $6.1M | — | ||
| Q3 24 | $6.0M | — | ||
| Q2 24 | $5.6M | $49.2M | ||
| Q1 24 | $5.9M | $-41.9M |
| Q4 25 | 36.6% | -333.6% | ||
| Q3 25 | 26.3% | -369.4% | ||
| Q2 25 | 35.3% | — | ||
| Q1 25 | 31.6% | — | ||
| Q4 24 | 34.2% | — | ||
| Q3 24 | 32.4% | — | ||
| Q2 24 | 31.9% | 54.3% | ||
| Q1 24 | 33.3% | — |
| Q4 25 | 26.5% | -342.3% | ||
| Q3 25 | 19.5% | -362.7% | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 25.9% | — | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 23.6% | 51.4% | ||
| Q1 24 | 24.0% | — |
| Q4 25 | $0.63 | $-0.21 | ||
| Q3 25 | $0.46 | $-0.21 | ||
| Q2 25 | $0.58 | — | ||
| Q1 25 | $0.51 | — | ||
| Q4 24 | $0.55 | — | ||
| Q3 24 | $0.54 | — | ||
| Q2 24 | $0.50 | $0.22 | ||
| Q1 24 | $0.51 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $136.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.6M | $-122.8M |
| Total Assets | $2.6B | $172.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $136.9M | ||
| Q3 25 | — | $180.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $354.5M | ||
| Q1 24 | — | $244.4M |
| Q4 25 | $338.6M | $-122.8M | ||
| Q3 25 | $334.3M | $-82.3M | ||
| Q2 25 | $330.6M | — | ||
| Q1 25 | $329.3M | — | ||
| Q4 24 | $324.4M | — | ||
| Q3 24 | $321.7M | — | ||
| Q2 24 | $315.3M | $81.5M | ||
| Q1 24 | $314.2M | $26.7M |
| Q4 25 | $2.6B | $172.2M | ||
| Q3 25 | $2.6B | $208.8M | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.6B | $373.4M | ||
| Q1 24 | $2.6B | $259.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $-48.3M |
| Free Cash FlowOCF − Capex | $30.1M | — |
| FCF MarginFCF / Revenue | 116.2% | — |
| Capex IntensityCapex / Revenue | 6.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.64× | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.8M | $-48.3M | ||
| Q3 25 | $7.3M | $-36.2M | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $9.3M | — | ||
| Q4 24 | $30.4M | — | ||
| Q3 24 | $9.6M | — | ||
| Q2 24 | $7.7M | $116.3M | ||
| Q1 24 | $5.1M | $-52.3M |
| Q4 25 | $30.1M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $5.6M | — | ||
| Q1 25 | $9.1M | — | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $3.9M | — |
| Q4 25 | 116.2% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 121.1% | — | ||
| Q3 24 | 36.6% | — | ||
| Q2 24 | 31.2% | — | ||
| Q1 24 | 16.1% | — |
| Q4 25 | 6.7% | 0.0% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.0% | 0.0% | ||
| Q1 24 | 4.7% | — |
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.37× | 2.36× | ||
| Q1 24 | 0.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
